Taizhou Baiying Biotechnology
PrivateLast Round
Series B
Sep 2, 2022
Total Funding Raised
$92.05M
Momentum Score
25 /100
Company Overview
Biointron is a biotechnology company specializing in recombinant antibody technology and contract research organization (CRO) services aimed at streamlining the antibody discovery process through advanced expression platforms, sequencing, and labeling tools.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Taizhou Baiying Biotechnology Comps
Public and private peers based on sector, stage, and business model.
Taizhou Baiying Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 2, 2022 | ||||
| Series A | May 24, 2021 | ||||
| Angel | Jul 23, 2018 |
Taizhou Baiying Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jifeng Ventures | Series B |
| Haitong Bank | Series B |
| Joy Capital | Series B |
| Jiangsu Provincial Government Investment Fund | Series B |
| Furong Investment | Series A |
| ALAN Asset Management | Series B |
| Jiangsu Tianyou Investment Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
New platform helps drug developers identify manufacturing problems early.
- Dec 17, 2025
Received the 2025 Scientist.com Supplier Performance Recognition Award.
Taizhou Baiying Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Taizhou Baiying Biotechnology's valuation, stock price, and market status.
